definiens: shall mean Dr. Ciccocioppo ’s entire right and tit le to and interest in all Intellectual Property Rights owned or held by Dr. Ciccocioppo related to PPAR  agonists, compositions containing PPAR  agonist(s ) alone or in combinat ion with other † DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION -1- therapeutic agents, and therapeutic methods and use s for PPAR  agonists and compositions containing PPAR  agonist(s ) alone or in combination with other ther apeutic agents, whether such compositions are administered alone or in conjunction with other the rapeutic agents or modalities, as of the Effective Date or invented, developed, advanced or improved by Dr. Ci ccocioppo during the term of this Agreement, including, without limitation, methods and composit ions for the use of PPAR  agonists, singly or in combination and/or in conjunction with other therap eutic agents, for prevention and treatment related to alcoholism and addictive disorders ( e.g., addiction s to alcohol, nicotine, marijuana, opioid agonists, benzodiazepine, barbiturates, psychostimulants and addictive or compulsive behaviors ), and the use of PPAR  agonists in combination and/or in conjunction with the administration of narcotic analgesics ( e.g., t o delay or prevent the development of tolerance and / o r addiction to opioid agonists ) or for the treatmen t of other central nervous system conditions, diseases a nd disorders, and all improvements or inventions re lated to the foregoing examples, the Assigned Patents and all inventions disclosed and/or claimed in the Ass igned Patents, and the future right to file US, ex - US and international patent applications for any other in ventions that are included in the Assigned IP or that become included in the Assigned IP during the term of thi s Agreement, in Dr. Ciccocioppo ’s name or in the name of [COMPANY], as well as all patents issuing from suc h patent applications